Marex Group’s Moderna MRNA Stock Holding History

Marex Group’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.23M	Buy	63,622 +35,104	+123%	+$1.64M	0.03%	266
2025 Q4	$841K	Sell	28,518 -207,837	-88%	-$5.65M	0.01%	436
2025 Q3	$6.11M	Buy	236,355 +223,356	+1,718%	+$6.23M	0.08%	176
2025 Q2	$359K	Sell	12,999 -116,901	-90%	-$3.08M	0.01%	416
2025 Q1	$3.68M	Buy	129,900 +43,000	+49%	+$1.53M	0.07%	128
2024 Q4	$3.61M	Buy	86,900 +67,635	+351%	+$3.23M	0.06%	113
2024 Q3	$1.29M	Buy	19,265 +3,920	+26%	+$360K	0.03%	195
2024 Q2	$1.82M	Sell	15,345 -1,250	-8%	-$158K	0.05%	168
2024 Q1	$1.77M	Buy	16,595 +2,305	+16%	+$232K	0.06%	143
2023 Q4	$1.42M	Buy	14,290 +5,825	+69%	+$490K	0.06%	184
2023 Q3	$874K	Buy	+8,465	New	+$944K	0.12%	80
2023 Q2	–	Sell	-6,535	Closed	-$1M	–	283
2023 Q1	$1M	Sell	6,535 -20,451	-76%	-$3.37M	0.13%	107
2022 Q4	$4.83M	Buy	+26,986	New	+$4.41M	0.69%	29

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return